$4.72 Billion is the total value of Rock Springs Capital Management LP's 155 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 26.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $150,964,000 | +7.1% | 1,575,000 | +7.5% | 3.20% | -10.5% |
| IRTC | IRHYTHM TECHNOLOGIES INC | $148,256,000 | -0.4% | 625,000 | 0.0% | 3.14% | -16.7% | |
| UNH | UNITEDHEALTH GROUP INC | $142,025,000 | +12.5% | 405,000 | 0.0% | 3.01% | -6.0% | |
| HUM | Buy | HUMANA INC | $116,927,000 | +16.5% | 285,000 | +17.5% | 2.48% | -2.7% |
| ZLAB | Buy | ZAI LAB LTDadr | $115,702,000 | +68.9% | 854,899 | +3.8% | 2.45% | +41.1% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $109,344,000 | +97.5% | 2,523,521 | +59.6% | 2.32% | +65.1% |
| ISRG | INTUITIVE SURGICAL INC | $98,172,000 | +15.3% | 120,000 | 0.0% | 2.08% | -3.6% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $94,430,000 | +6.9% | 842,000 | -11.6% | 2.00% | -10.7% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $87,371,000 | +86.6% | 163,500 | +14.3% | 1.85% | +56.0% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $86,204,000 | +32.8% | 1,612,500 | +2.5% | 1.83% | +11.0% |
| ARGX | ARGENX SEsponsored adr | $84,551,000 | +12.0% | 287,500 | 0.0% | 1.79% | -6.4% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $81,959,000 | +41.5% | 373,152 | +7.0% | 1.74% | +18.3% |
| PODD | Buy | INSULET CORP | $81,290,000 | +8.9% | 318,000 | +0.8% | 1.72% | -9.0% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $78,421,000 | +65.4% | 566,500 | -1.8% | 1.66% | +38.2% |
| NVTA | Buy | INVITAE CORP | $77,435,000 | +17.7% | 1,852,067 | +22.0% | 1.64% | -1.7% |
| HCA | Sell | HCA HEALTHCARE INC | $74,007,000 | +18.7% | 450,000 | -10.0% | 1.57% | -0.8% |
| FRPT | FRESHPET INC | $71,918,000 | +27.2% | 506,500 | 0.0% | 1.52% | +6.3% | |
| AVIR | New | ATEA PHARMACEUTICALS INC | $70,917,000 | – | 1,697,403 | +100.0% | 1.50% | – |
| NVRO | Buy | NEVRO CORP | $68,375,000 | +27.2% | 395,000 | +2.3% | 1.45% | +6.3% |
| EXAS | Buy | EXACT SCIENCES CORP | $64,258,000 | +48.7% | 485,000 | +14.4% | 1.36% | +24.2% |
| ARVN | Buy | ARVINAS INC | $63,358,000 | +457.4% | 746,000 | +54.9% | 1.34% | +366.3% |
| NVAX | Sell | NOVAVAX INC | $62,803,000 | -1.0% | 563,205 | -3.8% | 1.33% | -17.3% |
| IDXX | IDEXX LABS INC | $62,484,000 | +27.2% | 125,000 | 0.0% | 1.32% | +6.3% | |
| PCRX | Buy | PACIRA BIOSCIENCES INC | $61,336,000 | +1.5% | 1,025,000 | +2.0% | 1.30% | -15.1% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $58,138,000 | -5.6% | 225,000 | +4.7% | 1.23% | -21.1% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $56,049,000 | +15.5% | 328,750 | -4.8% | 1.19% | -3.5% |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $54,914,000 | +56.4% | 2,063,667 | +9.5% | 1.16% | +30.6% |
| TFX | TELEFLEX INCORPORATED | $53,504,000 | +20.9% | 130,000 | 0.0% | 1.13% | +1.0% | |
| EW | EDWARDS LIFESCIENCES CORP | $53,096,000 | +14.3% | 582,000 | 0.0% | 1.13% | -4.5% | |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $47,927,000 | +86.1% | 306,750 | +36.3% | 1.02% | +55.6% |
| ALLK | Buy | ALLAKOS INC | $47,810,000 | +143.0% | 341,500 | +41.4% | 1.01% | +103.2% |
| PHR | Buy | PHREESIA INC | $46,121,000 | +79.4% | 850,000 | +6.2% | 0.98% | +50.0% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $45,719,000 | -9.5% | 625,000 | -3.8% | 0.97% | -24.4% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $44,260,000 | +92.9% | 713,865 | +0.5% | 0.94% | +61.2% |
| CNC | Sell | CENTENE CORP DEL | $43,822,000 | -43.1% | 730,000 | -44.7% | 0.93% | -52.5% |
| SGEN | New | SEAGEN INC | $43,785,000 | – | 250,000 | +100.0% | 0.93% | – |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $43,540,000 | -12.0% | 335,000 | -1.4% | 0.92% | -26.5% |
| EHC | Sell | ENCOMPASS HEALTH CORP | $41,345,000 | -8.8% | 500,000 | -28.4% | 0.88% | -23.8% |
| IMVT | Buy | IMMUNOVANT INC | $41,155,000 | +57.5% | 891,000 | +20.0% | 0.87% | +31.7% |
| EAR | New | EARGO INC | $40,338,000 | – | 900,000 | +100.0% | 0.86% | – |
| INSP | Sell | INSPIRE MED SYS INC | $40,129,000 | +31.8% | 213,350 | -9.6% | 0.85% | +10.1% |
| SPRB | New | SPRUCE BIOSCIENCES INC | $39,650,000 | – | 1,631,000 | +100.0% | 0.84% | – |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $38,943,000 | +8.1% | 233,500 | 0.0% | 0.83% | -9.6% | |
| ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $37,548,000 | +21.6% | 635,000 | 0.0% | 0.80% | +1.5% | |
| CVET | Buy | COVETRUS INC | $36,931,000 | +23.6% | 1,285,000 | +4.9% | 0.78% | +3.3% |
| ACHC | Sell | ACADIA HEALTHCARE COMPANY IN | $35,182,000 | +57.0% | 700,000 | -7.9% | 0.75% | +31.3% |
| LUNG | New | PULMONX CORP | $34,510,000 | – | 500,000 | +100.0% | 0.73% | – |
| HCAT | Buy | HEALTH CATALYST INC | $34,171,000 | +32.8% | 785,000 | +11.7% | 0.72% | +11.0% |
| ARDX | Buy | ARDELYX INC | $33,308,000 | +25.0% | 5,148,112 | +1.4% | 0.71% | +4.4% |
| NKTX | Buy | NKARTA INC | $33,255,000 | +104.5% | 541,000 | +0.0% | 0.70% | +70.7% |
| BIIB | New | BIOGEN INCcall | $31,832,000 | – | 130,000 | +100.0% | 0.68% | – |
| NVCR | NOVOCURE LTD | $30,282,000 | +55.5% | 175,000 | 0.0% | 0.64% | +30.0% | |
| ATHA | Sell | ATHIRA PHARMA INC | $29,486,000 | +44.9% | 860,902 | -21.9% | 0.62% | +21.1% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $28,760,000 | -31.6% | 800,000 | -27.3% | 0.61% | -42.8% |
| BFAM | BRIGHT HORIZONS FAM SOL IN D | $28,630,000 | +13.8% | 165,500 | 0.0% | 0.61% | -4.9% | |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $28,545,000 | -5.4% | 256,768 | +1.0% | 0.60% | -21.0% |
| PEN | PENUMBRA INC | $27,825,000 | -10.0% | 159,000 | 0.0% | 0.59% | -24.7% | |
| TVTX | New | TRAVERE THERAPEUTICS INC | $27,827,000 | – | 1,021,000 | +100.0% | 0.59% | – |
| EPZM | Buy | EPIZYME INC | $27,728,000 | -8.9% | 2,553,208 | +0.1% | 0.59% | -23.8% |
| MIRM | Buy | MIRUM PHARMACEUTICALS INC | $26,129,000 | +2.1% | 1,496,525 | +12.7% | 0.55% | -14.6% |
| INCY | INCYTE CORP | $26,094,000 | -3.1% | 300,000 | 0.0% | 0.55% | -19.0% | |
| PRLD | Buy | PRELUDE THERAPEUTICS INC | $25,784,000 | +137.5% | 360,363 | +0.0% | 0.55% | +98.9% |
| GH | Buy | GUARDANT HEALTH INC | $25,776,000 | +21.4% | 200,000 | +5.3% | 0.55% | +1.5% |
| STTK | New | SHATTUCK LABS INC | $25,628,000 | – | 489,000 | +100.0% | 0.54% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $25,438,000 | +39.2% | 489,000 | -28.4% | 0.54% | +16.2% |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $24,783,000 | +31.3% | 243,950 | -0.1% | 0.52% | +9.6% |
| BIIB | Sell | BIOGEN INC | $24,486,000 | -50.0% | 100,000 | -42.0% | 0.52% | -58.2% |
| BAX | Sell | BAXTER INTL INC | $24,152,000 | -53.4% | 301,000 | -53.3% | 0.51% | -61.1% |
| RPRX | Sell | ROYALTY PHARMA PLC | $24,024,000 | +17.7% | 480,000 | -1.0% | 0.51% | -1.7% |
| SPRO | Sell | SPERO THERAPEUTICS INC | $23,947,000 | +73.6% | 1,235,000 | -0.1% | 0.51% | +45.1% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $23,760,000 | +64.4% | 1,029,000 | +0.5% | 0.50% | +37.3% |
| OSH | Buy | OAK STR HEALTH INC | $22,935,000 | +43.1% | 375,000 | +25.0% | 0.49% | +19.4% |
| SWAV | SHOCKWAVE MED INC | $22,818,000 | +36.8% | 220,000 | 0.0% | 0.48% | +14.4% | |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $22,229,000 | -16.5% | 253,500 | -27.6% | 0.47% | -30.3% |
| COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $22,033,000 | -9.9% | 1,100,000 | -6.4% | 0.47% | -24.8% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $21,956,000 | – | 400,370 | +100.0% | 0.47% | – |
| ACCD | Buy | ACCOLADE INC | $21,750,000 | +72.2% | 500,000 | +53.8% | 0.46% | +43.6% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $20,514,000 | +12.0% | 4,195,000 | -3.6% | 0.44% | -6.5% |
| CHRS | Sell | COHERUS BIOSCIENCES INC | $20,204,000 | -33.9% | 1,162,500 | -30.2% | 0.43% | -44.8% |
| ABCM | New | ABCAM PLCads | $19,934,000 | – | 925,000 | +100.0% | 0.42% | – |
| PPD | PPD INC | $17,966,000 | -7.5% | 525,000 | 0.0% | 0.38% | -22.7% | |
| GMDA | Buy | GAMIDA CELL LTD | $17,569,000 | +109.9% | 2,094,000 | +3.8% | 0.37% | +75.9% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $17,314,000 | +224.5% | 2,676,100 | +28.9% | 0.37% | +171.9% |
| CYTOKINETICS INCnote 4.000%11/1 | $17,270,000 | -3.0% | 8,000,000 | 0.0% | 0.37% | -19.0% | ||
| RLAY | Sell | RELAY THERAPEUTICS INC | $17,123,000 | -2.8% | 412,000 | -0.4% | 0.36% | -18.8% |
| INZY | Sell | INOZYME PHARMA INC | $17,142,000 | -25.9% | 830,546 | -5.6% | 0.36% | -38.2% |
| RIGL | RIGEL PHARMACEUTICALS INC | $16,600,000 | +45.8% | 4,742,891 | 0.0% | 0.35% | +21.8% | |
| KURA | New | KURA ONCOLOGY INC | $16,595,000 | – | 508,116 | +100.0% | 0.35% | – |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $16,563,000 | – | 999,000 | +100.0% | 0.35% | – |
| GLPG | Sell | GALAPAGOS NVspon adr | $16,332,000 | -34.2% | 165,000 | -5.7% | 0.35% | -45.1% |
| XENT | Buy | INTERSECT ENT INC | $16,030,000 | +96.6% | 700,000 | +40.0% | 0.34% | +64.3% |
| TARA | Sell | PROTARA THERAPEUTICS INC | $15,572,000 | +43.8% | 643,200 | -0.1% | 0.33% | +20.0% |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $14,578,000 | +45.0% | 490,339 | +5.7% | 0.31% | +21.2% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $14,442,000 | +76.1% | 87,500 | +52.2% | 0.31% | +47.1% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $14,224,000 | +97.4% | 515,000 | +0.4% | 0.30% | +65.0% |
| GOSSAMER BIO INCnote 5.000% 6/0 | $14,184,000 | -11.6% | 15,573,000 | 0.0% | 0.30% | -26.0% | ||
| APLT | Sell | APPLIED THERAPEUTICS INC | $13,995,000 | -32.0% | 635,837 | -35.9% | 0.30% | -43.1% |
| GWPH | GW PHARMACEUTICALS PLCads | $13,755,000 | +18.5% | 119,188 | 0.0% | 0.29% | -0.7% | |
| PRTA | Buy | PROTHENA CORP PLC | $13,705,000 | +33.8% | 1,141,100 | +11.3% | 0.29% | +11.9% |
| CGEN | Buy | COMPUGEN LTDord | $13,728,000 | -25.4% | 1,133,600 | +0.1% | 0.29% | -37.7% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $13,297,000 | +2.1% | 515,371 | +21.8% | 0.28% | -14.5% |
| KNTE | New | KINNATE BIOPHARMA INC | $12,916,000 | – | 324,686 | +100.0% | 0.27% | – |
| AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $12,435,000 | +10.3% | 1,580,000 | -0.7% | 0.26% | -7.7% |
| FPRX | Buy | FIVE PRIME THERAPEUTICS INC | $12,275,000 | +862.0% | 721,633 | +165.7% | 0.26% | +712.5% |
| TBPH | Sell | THERAVANCE BIOPHARMA INC | $12,052,000 | -1.1% | 678,200 | -17.7% | 0.26% | -17.2% |
| TBIO | Buy | TRANSLATE BIO INC | $11,860,000 | +35.6% | 643,500 | +0.1% | 0.25% | +13.1% |
| FGEN | Buy | FIBROGEN INC | $11,475,000 | -9.8% | 309,387 | +0.0% | 0.24% | -24.8% |
| FUSN | Buy | FUSION PHARMACEUTICALS INC | $11,143,000 | -2.2% | 948,327 | +0.1% | 0.24% | -18.3% |
| NGM | Buy | NGM BIOPHARMACEUTICALS INC | $10,921,000 | +90.4% | 360,500 | +0.0% | 0.23% | +58.9% |
| TXG | 10X GENOMICS INC | $10,762,000 | +13.6% | 76,000 | 0.0% | 0.23% | -5.0% | |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $10,700,000 | -6.0% | 773,669 | +0.1% | 0.23% | -21.5% |
| KDNY | New | CHINOOK THERAPEUTICS INC | $10,608,000 | – | 668,849 | +100.0% | 0.22% | – |
| PRTK | Buy | PARATEK PHARMACEUTICALS INC | $10,521,000 | +16.2% | 1,680,614 | +0.4% | 0.22% | -3.0% |
| CHMA | Sell | CHIASMA INC | $9,294,000 | +0.8% | 2,136,514 | -0.4% | 0.20% | -15.8% |
| Sell | TRILLIUM THERAPEUTICS INC | $9,098,000 | -17.0% | 618,500 | -19.8% | 0.19% | -30.6% | |
| SRRA | New | SIERRA ONCOLOGY INC | $9,095,000 | – | 567,358 | +100.0% | 0.19% | – |
| LEGN | Buy | LEGEND BIOTECH CORPsponsored ads | $8,713,000 | +11.9% | 309,418 | +22.7% | 0.18% | -6.6% |
| CNMD | Sell | CONMED CORP | $8,736,000 | -38.3% | 78,000 | -56.7% | 0.18% | -48.5% |
| NRIX | Sell | NURIX THERAPEUTICS INC | $8,458,000 | -5.9% | 257,250 | -0.1% | 0.18% | -21.5% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $8,328,000 | -47.5% | 1,545,000 | -22.2% | 0.18% | -56.0% |
| WST | WEST PHARMACEUTICAL SVSC INC | $8,074,000 | +3.1% | 28,500 | 0.0% | 0.17% | -14.1% | |
| IMRA | Buy | IMARA INC | $7,949,000 | +8.9% | 360,500 | +0.4% | 0.17% | -8.6% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $7,921,000 | +38.7% | 515,000 | -0.1% | 0.17% | +15.9% |
| QURE | Sell | UNIQURE NV | $7,533,000 | -50.5% | 208,500 | -49.6% | 0.16% | -58.5% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $7,340,000 | +3.1% | 1,649,420 | +0.1% | 0.16% | -13.8% |
| BCEL | Buy | ATRECA INC | $7,287,000 | +15.7% | 451,230 | +0.1% | 0.16% | -3.1% |
| ODT | Sell | ODONATE THERAPEUTICS INC | $7,252,000 | +10.3% | 377,700 | -22.8% | 0.15% | -7.8% |
| MGNX | Buy | MACROGENICS INC | $7,075,000 | +6.9% | 309,510 | +17.8% | 0.15% | -10.7% |
| OSW | Sell | ONESPAWORLD HOLDINGS LIMITED | $6,997,000 | -38.1% | 690,000 | -60.3% | 0.15% | -48.4% |
| INSMED INCnote 1.750% 1/1 | $6,763,000 | +3.4% | 6,000,000 | 0.0% | 0.14% | -13.9% | ||
| CNST | Sell | CONSTELLATION PHARMCETICLS I | $6,703,000 | -35.8% | 232,743 | -54.9% | 0.14% | -46.4% |
| ANAB | Buy | ANAPTYSBIO INC | $6,652,000 | +45.9% | 309,413 | +0.1% | 0.14% | +21.6% |
| GRTX | GALERA THERAPEUTICS INC | $5,806,000 | +13.2% | 567,552 | 0.0% | 0.12% | -5.4% | |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $5,410,000 | -3.3% | 159,957 | -29.4% | 0.12% | -19.0% |
| HQY | Sell | HEALTHEQUITY INC | $5,228,000 | -71.7% | 75,000 | -79.2% | 0.11% | -76.3% |
| PANAU | PANACEA ACQUISITION CORPunit 99/99/9999 | $5,131,000 | +6.3% | 402,088 | 0.0% | 0.11% | -10.7% | |
| CERT | New | CERTARA INC | $5,058,000 | – | 150,000 | +100.0% | 0.11% | – |
| ACRX | Buy | ACELRX PHARMACEUTICALS INC | $4,690,000 | -12.5% | 3,782,457 | +0.2% | 0.10% | -27.2% |
| PHAS | Buy | PHASEBIO PHARMACEUTICALS INC | $4,416,000 | -4.2% | 1,314,374 | +0.1% | 0.09% | -19.7% |
| BLSA | New | BCLS ACQUISITION CORP | $3,442,000 | – | 309,000 | +100.0% | 0.07% | – |
| RETROPHIN INCnote 2.500% 9/1 | $3,311,000 | +19.1% | 3,250,000 | 0.0% | 0.07% | -1.4% | ||
| PSTX | Sell | POSEIDA THERAPEUTICS INC | $3,179,000 | -2.5% | 289,754 | -21.2% | 0.07% | -19.3% |
| CO | Sell | GLOBAL CORD BLOOD CORPORATIO | $2,875,000 | -10.2% | 775,000 | -14.3% | 0.06% | -24.7% |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $2,200,000 | – | 206,200 | +100.0% | 0.05% | – |
| EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $2,196,000 | – | 206,000 | +100.0% | 0.05% | – |
| TMPMU | New | TURMERIC ACQUISITION CORPunit 10/08/2025 | $2,116,000 | – | 206,000 | +100.0% | 0.04% | – |
| PHICU | New | POPULATION HEALTH INVS CO INunit 99/99/9999 | $2,101,000 | – | 201,044 | +100.0% | 0.04% | – |
| JYAC | New | JIYA ACQUISITION CORP | $2,124,000 | – | 206,200 | +100.0% | 0.04% | – |
| HLXA | New | HELIX ACQUISITION CORP | $1,757,000 | – | 154,500 | +100.0% | 0.04% | – |
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,420,000 | +7.6% | 1,500,000 | 0.0% | 0.03% | -9.1% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,390,000 | +0.4% | 1,000,000 | 0.0% | 0.03% | -17.1% | ||
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,348,000 | +8.4% | 1,500,000 | 0.0% | 0.03% | -9.4% | ||
| ANNX | Sell | ANNEXON INC | $1,137,000 | -84.1% | 45,413 | -80.8% | 0.02% | -86.8% |
| PACIRA BIOSCIENCES INCnote 2.375% 4/0 | $1,149,000 | -0.2% | 1,000,000 | 0.0% | 0.02% | -17.2% | ||
| NEVRO CORPnote 2.750% 4/0 | $912,000 | +17.7% | 500,000 | 0.0% | 0.02% | -5.0% | ||
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -185,150 | -100.0% | -0.01% | – |
| Exit | NABRIVA THERAPEUTICS PLC | $0 | – | -1,067,664 | -100.0% | -0.01% | – | |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -19,762 | -100.0% | -0.04% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -9,000 | -100.0% | -0.06% | – |
| PASG | Exit | PASSAGE BIO INC | $0 | – | -206,036 | -100.0% | -0.07% | – |
| OBSV | Exit | OBSEVA SA | $0 | – | -1,434,652 | -100.0% | -0.09% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -206,495 | -100.0% | -0.11% | – |
| GDRX | Exit | GOODRX HLDGS INC | $0 | – | -100,000 | -100.0% | -0.14% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -415,982 | -100.0% | -0.19% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -814,208 | -100.0% | -0.23% | – |
| APRE | Exit | APREA THERAPEUTICS INC | $0 | – | -518,290 | -100.0% | -0.32% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -1,024,261 | -100.0% | -0.48% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -0.53% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -1,463,915 | -100.0% | -0.61% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -250,000 | -100.0% | -1.24% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -1,587,500 | -100.0% | -3.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.